Lantheus to Present at the Jefferies London Healthcare Conference
Lantheus Holdings (NASDAQ: LNTH), a leading radiopharmaceutical company, has announced its participation in the upcoming Jefferies London Healthcare Conference. Bob Marshall, Chief Financial Officer and Treasurer, will deliver a presentation on Wednesday, November 20, at 1:00 p.m. GMT (8 a.m. EST). The presentation will be accessible via live webcast through the Investors section of Lantheus's website. A replay will remain available for at least 30 days after the live event.
Lantheus Holdings (NASDAQ: LNTH), una delle principali aziende di radiofarmaci, ha annunciato la sua partecipazione al prossimo Jefferies London Healthcare Conference. Bob Marshall, Direttore Finanziario e Tesoriere, terrà una presentazione mercoledì 20 novembre, alle 13:00 GMT (8:00 EST). La presentazione sarà disponibile tramite un webcast in diretta nella sezione per gli Investitori del sito web di Lantheus. Una registrazione rimarrà disponibile per almeno 30 giorni dopo l'evento dal vivo.
Lantheus Holdings (NASDAQ: LNTH), una de las principales compañías de radiofármacos, ha anunciado su participación en la próxima Jefferies London Healthcare Conference. Bob Marshall, Director Financiero y Tesorero, realizará una presentación el miércoles 20 de noviembre, a la 1:00 p.m. GMT (8:00 a.m. EST). La presentación estará disponible a través de una retransmisión en vivo en la sección para Inversores del sitio web de Lantheus. Una repetición estará disponible durante al menos 30 días después del evento en vivo.
Lantheus Holdings (NASDAQ: LNTH), 주요 방사성 의약품 회사가 다가오는 Jefferies London Healthcare Conference에 참여한다고 발표했습니다. Bob Marshall, 최고 재무 책임자 겸 재무관이 11월 20일 수요일 오후 1시 GMT (오전 8시 EST)에 발표를 진행할 예정입니다. 발표는 Lantheus 웹사이트의 투자자 섹션을 통해 실시간 웹캐스트로 접속할 수 있습니다. 실시간 이벤트 이후 최소 30일 동안 재생이 가능할 것입니다.
Lantheus Holdings (NASDAQ: LNTH), une entreprise de premier plan dans le domaine des radio-pharmaceutiques, a annoncé sa participation à la prochaine Jefferies London Healthcare Conference. Bob Marshall, Directeur Financier et Trésorier, présentera une intervention le mercredi 20 novembre à 13h00 GMT (8h00 EST). La présentation sera accessible via un webcast en direct dans la section Investisseurs du site web de Lantheus. Une rediffusion sera disponible pendant au moins 30 jours après l'événement en direct.
Lantheus Holdings (NASDAQ: LNTH), ein führendes Unternehmen im Bereich der Radiopharmazeutika, hat seine Teilnahme an der bevorstehenden Jefferies London Healthcare Conference bekannt gegeben. Bob Marshall, Chief Financial Officer und Schatzmeister, wird am Mittwoch, den 20. November, um 13:00 Uhr GMT (08:00 Uhr EST) eine Präsentation halten. Die Präsentation wird über einen Live-Webcast im Bereich Investoren der Lantheus-Website zugänglich sein. Eine Aufzeichnung wird mindestens 30 Tage nach der Live-Veranstaltung verfügbar sein.
- None.
- None.
BEDFORD, Mass., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced Bob Marshall, Chief Financial Officer and Treasurer, will present at the Jefferies London Healthcare Conference at 1:00 p.m. GMT (8 a.m. EST) on Wednesday, November 20.
To access a live webcast of the presentation, please visit the Investors section of the Company’s website at www.lantheus.com. A replay of the webcast will be available on the Company’s website for at least 30 days following the live presentation.
About Lantheus
Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in Canada and Sweden, Lantheus has been providing radiopharmaceutical solutions for more than 65 years. For more information, visit www.lantheus.com.
Contacts:
Mark Kinarney
Vice President, Investor Relations
978-671-8842
ir@lantheus.com
Melissa Downs
Senior Director, External Communications
646-975-2533
media@lantheus.com
FAQ
When is Lantheus (LNTH) presenting at the Jefferies London Healthcare Conference?
How can investors watch Lantheus (LNTH) Jefferies Conference presentation?
How long will the Lantheus (LNTH) Jefferies Conference presentation replay be available?
Who is representing Lantheus (LNTH) at the Jefferies London Healthcare Conference?
